Abstract:The present study assessed the role of the p53 tumor suppressor gene in cell cycle arrest and apoptosis following treatment of Burkitt's lymphoma and lymphoblastoid cell lines with gamma-rays, etoposide, nitrogen mustard, and cisplatin. Cell cycle arrest was measured by flow cytometry; p53 and p21Waf1/Cip1 protein levels were measured by Western blotting; cell survival was measured in 72-96-h growth inhibition assays and by trypan blue staining, and apoptotic DNA fragmentation was assessed by either agarose gel electrophoresis or a modified filter elution method. We found that gamma-rays and etoposide induced a strong G1 arrest in the wild-type p53 lines while nitrogen mustard and cisplatin induced relatively little G1 arrest. All agents failed to induce G1 arrest in cells containing mutant p53 genes. The degree of G1 arrest observed with these agents correlated with the rate of p53 and p21Waf1/Cip1 protein accumulation: gamma-rays and etoposide induced rapid accumulation of both p53 and p21Waf1/Cip1; nitrogen mustard and cisplatin induced slow accumulation of p53 and no major accumulation of the p21Waf1/Cip1 protein. Despite differences in G1 arrest and kinetics of p53 or p21Waf1/Cip1 protein accumulation, all agents tended to decrease survival to a greater extent in the wild-type p53 lines compared to the mutant p53 lines. Cell death in the wild-type p53 lines was associated with intracellular DNA degradation into oligonucleosomal sized DNA fragments, indicative of apoptosis. We also observed an inverse sensitivity relationship between nitrogen mustard/cisplatin and etoposide in the mutant p53 lines and this was found to correlate with topoisomerase II mRNA levels in the cells. Our results suggest that p53 gene status is an important determinant of both radio- and chemosensitivity in lymphoid cell lines and that p53 mutations are often associated with decreased sensitivity to DNA damaging agents.

Cell cycle arrest and apoptosis are not dependent on p53 prior to p53-dependent embryonic stem cell differentiation

P53 and P73 Regulate Apoptosis but Not Cell-Cycle Progression in Mouse Embryonic Stem Cells Upon DNA Damage and Differentiation

Regulation of Apoptosis and Differentiation by P53 in Human Embryonic Stem Cells*

P53 Induces Differentiation of Mouse Embryonic Stem Cells by Suppressing Nanog Expression

P53 Transcriptional Activity is Essential for P53-Dependent Apoptosis Following DNA Damage

A New Role for P53 in Maintaining Genetic Stability in Embryonic Stem Cells

p53 and stem cells: new developments and new concerns.

P53 and Stem Cells: New Developments and New Concerns

A Genomewide Study Identifies the Wnt Signaling Pathway As a Major Target of P53 in Murine Embryonic Stem Cells

Functions of P53 in Pluripotent Stem Cells

Ets1 is Required for P53 Transcriptional Activity in Uv-Induced Apoptosis in Embryonic Stem Cells

Oct4 Maintains the Pluripotency of Human Embryonic Stem Cells by Inactivating P53 Through Sirt1-Mediated Deacetylation

p57 Suppresses the Pluripotency and Proliferation of Mouse Embryonic Stem Cells by Positively Regulating p53 Activation

Levels of p53 expression determine the competitive ability of embryonic stem cells during the onset of differentiation

An Apela RNA-Containing Negative Feedback Loop Regulates p53-Mediated Apoptosis in Embryonic Stem Cells.

Inhibition of Apoptosis Reduces Diploidization of Haploid Mouse Embryonic Stem Cells During Differentiation

Differentiated Embryo-Chondrocyte Expressed Gene 1 Regulates P53-Dependent Cell Survival Versus Cell Death Through Macrophage Inhibitory Cytokine-1

Puma is Required for P53-Induced Depletion of Adult Stem Cells

p53 Regulates Hematopoietic Stem Cell Quiescence

DNA Damage Response and Cell Cycle Regulation in Pluripotent Stem Cells

P53 Gene Mutations Are Associated with Decreased Sensitivity of Human Lymphoma Cells to DNA Damaging Agents.